FI890373A0 - Sv40-uttryckningsvektor innehaollande hbxag som uttryckningsmarkoer. - Google Patents

Sv40-uttryckningsvektor innehaollande hbxag som uttryckningsmarkoer.

Info

Publication number
FI890373A0
FI890373A0 FI890373A FI890373A FI890373A0 FI 890373 A0 FI890373 A0 FI 890373A0 FI 890373 A FI890373 A FI 890373A FI 890373 A FI890373 A FI 890373A FI 890373 A0 FI890373 A0 FI 890373A0
Authority
FI
Finland
Prior art keywords
uttryckningsvektor
uttryckningsmarkoer
hbxag
innehaollande
som
Prior art date
Application number
FI890373A
Other languages
English (en)
Other versions
FI890373A (fi
FI101966B1 (fi
FI101966B (fi
Inventor
Ann M Moriarty
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of FI890373A publication Critical patent/FI890373A/fi
Publication of FI890373A0 publication Critical patent/FI890373A0/fi
Application granted granted Critical
Publication of FI101966B1 publication Critical patent/FI101966B1/fi
Publication of FI101966B publication Critical patent/FI101966B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI890373A 1987-05-26 1989-01-25 Antigeeninen, synteettinen polypeptidi sekä sen käyttö diagnostiikassa FI101966B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/054,424 US4942125A (en) 1984-09-07 1987-05-26 SV40 expression vector containing HBxAg as an expression marker
US5442487 1987-05-26
PCT/US1988/001719 WO1988009340A1 (en) 1987-05-26 1988-05-24 A SV40 EXPRESSION VECTOR CONTAINING HBxAg AS AN EXPRESSION MARKER
US8801719 1988-05-24

Publications (4)

Publication Number Publication Date
FI890373A FI890373A (fi) 1989-01-25
FI890373A0 true FI890373A0 (fi) 1989-01-25
FI101966B1 FI101966B1 (fi) 1998-09-30
FI101966B FI101966B (fi) 1998-09-30

Family

ID=21990971

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890373A FI101966B (fi) 1987-05-26 1989-01-25 Antigeeninen, synteettinen polypeptidi sekä sen käyttö diagnostiikassa

Country Status (9)

Country Link
US (1) US4942125A (fi)
EP (1) EP0316425A4 (fi)
JP (1) JPH02500245A (fi)
KR (1) KR0127148B1 (fi)
AU (1) AU614972B2 (fi)
CA (1) CA1326109C (fi)
DK (1) DK174060B1 (fi)
FI (1) FI101966B (fi)
WO (1) WO1988009340A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
ES2167304T3 (es) * 1987-06-22 2002-05-16 Medeva Holdings Bv Peptido que contiene el antigeno de superficie de la hepatitis b.
DE3841755A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
JPH06502311A (ja) * 1990-10-22 1994-03-17 フォックス・チェイス・キャンサー・センター Ｒｎａ療法を提供するためのｄｎａ構造
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
US20030100520A1 (en) * 1997-01-21 2003-05-29 Philip Needleman Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker

Also Published As

Publication number Publication date
EP0316425A4 (en) 1991-03-20
FI890373A (fi) 1989-01-25
KR0127148B1 (ko) 1997-12-29
JPH02500245A (ja) 1990-02-01
US4942125A (en) 1990-07-17
AU1805088A (en) 1988-12-21
DK32089A (da) 1989-03-21
DK174060B1 (da) 2002-05-13
FI101966B1 (fi) 1998-09-30
WO1988009340A1 (en) 1988-12-01
CA1326109C (en) 1994-01-11
AU614972B2 (en) 1991-09-19
DK32089D0 (da) 1989-01-25
FI101966B (fi) 1998-09-30
KR890701623A (ko) 1989-12-21
EP0316425A1 (en) 1989-05-24

Similar Documents

Publication Publication Date Title
FI884063A (fi) Hydrokrackningskatalysatorer och -foerfaranden som anvaender icke-zeolitiska molekylsaoll.
FI884924A (fi) Humanimmuglobulin som producerats med hybrid-dna-teknik.
FI884224A0 (fi) Modeanpassad diodpumpad halvledarlaser.
FI880894A (fi) Boejliga slipmedel.
FI874468A0 (fi) Sjaelvbevattningskruka.
IT8821018A0 (it) Proietto.
FI884844A0 (fi) Sanitetsmedel.
FI902042A0 (fi) Bencement som innehaoller celltillvaextstimulans.
FI870569A0 (fi) Anordning foer taetning av en kammare som innehaoller tryckmedium.
FI884178A0 (fi) Foerpackningsmaskin.
FI884681A (fi) Polyamidbasfoereningar som gjorts eldfasta.
FI884721A0 (fi) Anvaendning av fluorderivat som kontrastmedel.
FI880562A (fi) Heterocykliska foereningar.
FI882708A0 (fi) Skyddsanordning foer en inloppsspalt.
FI893189A0 (fi) Tetrahaloftalatestrar som brandskyddsvaetskor foer vissa hartser.
FI882643A0 (fi) Foerfarande foer framstaellning av en silan- eller siloxanfoerening som innehaoller minst en cykloalkylring.
FI875236A0 (fi) Maetningsgivare foer baerbar analysator.
FI890373A0 (fi) Sv40-uttryckningsvektor innehaollande hbxag som uttryckningsmarkoer.
FI880882A0 (fi) Valsanordning.
FI884926A (fi) Kopolymerbestrykningskompositioner som innehaoller sulfoalkylmonomeremulsionsmedel.
DE3873615T2 (de) Polycyanoarylthioether.
DE3767300D1 (de) Falschdrall-kraeuselmaschine.
FI880404A0 (fi) Anslutningshuvud.
FI880313A (fi) Behaollare.
FI872472A0 (fi) Konstruktionssystem foer madrasskombinationer.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: SCRIPPS CLINIC AND RESEARCH FOUNDATION

MA Patent expired